Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Growth Hormone & IGF Research

• Publication date

  2005-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.GHIR.2004.11.001PMID 15701567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy.

  2005cited by this paper
• Tissue specific expression of an α-skeletal actin-lacZ fusion gene during development in transgenic mice

  2005influential reference
• Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1.

  2004influential reference
• Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.

  2004cited by this paper
• Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.

  2004influential reference
• Early Regeneration of Whole Skeletal Muscle Grafts Is Unaffected by Overexpression of IGF-1 in MLC/mIGF-1 Transgenic Mice

  2004cited by this paper
• Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis.

  2004cited by this paper
• Persistent IGF-I overexpression in skeletal muscle transiently enhances DNA accretion and growth.

  2003cited by this paper
• Targeted Expression of IGF‐1 Transgene to Skeletal Muscle Accelerates Muscle and Motor Neuron Regeneration

  2003influential reference
• Expression and Splicing of the Insulin‐Like Growth Factor Gene in Rodent Muscle is Associated with Muscle Satellite (stem) Cell Activation following Local Tissue Damage

  2003cited by this paper
• Expression of IGF‐I splice variants in young and old human skeletal muscle after high resistance exercise

  2003influential reference
• Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise.[see comment]

  2003cited by this paper
• Different modes of hypertrophy in skeletal muscle fibers

  2002cited by this paper
• Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

  2002influential reference
• Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease.

  2002cited by this paper
• Nucleolar localization of an isoform of the IGF-I precursor

  2002cited by this paper
• Different roles of the IGF‐I Ec peptide (MGF) and mature IGF‐I in myoblast proliferation and differentiation

  2002influential reference
• Protein calorie restriction affects nonhepatic IGF-I production and the lymphoid system: studies using the liver-specific IGF-I gene-deleted mouse model.

  2002cited by this paper
• Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration.

  2002cited by this paper
• Persistent IGF‐I overexpression in skeletal muscle transiently enhances DNA accretion and growth 1

  2002influential reference
• Selected contribution: acute cellular and molecular responses to resistance exercise.

  2002cited by this paper
• Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

  2001cited by this paper
• The evolution of controlled multitasked gene networks: the role of introns and other noncoding RNAs in the development of complex organisms.

  2001cited by this paper
• The somatomedin hypothesis: 2001.

  2001cited by this paper
• Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children.

  2000cited by this paper
• Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway.

  2000cited by this paper
• Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.

  2000cited by this paper
• Insulin-like Growth Factor-I Extends in VitroReplicative Life Span of Skeletal Muscle Satellite Cells by Enhancing G1/S Cell Cycle Progression via the Activation of Phosphatidylinositol 3′-Kinase/Akt Signaling Pathway*

  2000cited by this paper
• Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology

  2000influential reference
• Local insulin‐like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice

  1999influential reference
• Higher content of insulin-like growth factor-I in dystrophic mdx mouse: potential role in the spontaneous regeneration through an electrophysiological investigation of muscle function.

  1999influential reference
• Expression of insulin growth factor‐1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation

  1999cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Insulin-Like Growth Factor I Is Essential for Postnatal Growth in Response to Growth Hormone

  1999cited by this paper
• Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function.

  1998cited by this paper
• Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy.

  1998cited by this paper
• Overexpression of IGF-I in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy.

  1998influential reference
• Purification, amino acid sequence and characterisation of kangaroo IGF-I.

  1998cited by this paper
• Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice.

  1997cited by this paper
• Quantitative study of the effects of long‐term denervation on the extensor digitorum longus muscle of the rat

  1997cited by this paper
• Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors.

  1997cited by this paper
• Net Fluxes Over Working Thigh of Hormones, Growth Factors and Biomarkers of Bone Metabolism During Short Lasting Dynamic Exercise

  1997cited by this paper
• Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice.

  1996cited by this paper
• Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch

  1996cited by this paper
• An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide.

  1995cited by this paper
• Mutational Analysis of the Insulin-like Growth Factor I Prohormone Processing Site (*)

  1995cited by this paper
• Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*)

  1995cited by this paper
• Alternative leader sequences in insulin-like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides.

  1995influential reference
• Insulin‐like Growth Factors

  1993cited by this paper
• Sequence of a cDNA encoding dog insulin-like growth factor I.

  1993cited by this paper
• The porcine insulin-like growth factor-I gene: characterization and expression of alternate transcription sites.

  1993cited by this paper
• General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.

  1993cited by this paper
• Multiple transcription start sites in the rat insulin-like growth factor-I gene give rise to IGF-I mRNAs that encode different IGF-I precursors and are processed differently in vitro.

  1993influential reference
• The Biological Role of Truncated Insulin‐like Growth Factor‐1 and the Tripeptide GPE in the Central Nervous System a

  1993cited by this paper
• Expression of α‐cardiac and α‐skeletal actin mRNAs in relation to innervation in regenerating and non‐regenerating rat skeletal muscles

  1992cited by this paper
• Tissue-specific transcription start site usage in the leader exons of the rat insulin-like growth factor-I gene: evidence for differential regulation in the developing kidney.

  1992cited by this paper
• Expression of alpha-cardiac and alpha-skeletal actin mRNAs in relation to innervation in regenerating and non-regenerating rat skeletal muscles.

  1992cited by this paper
• The ovine insulin-like growth factor-I gene: characterization, expression and identification of a putative promoter.

  1991cited by this paper
• Fiber type- and position-dependent expression of a myosin light chain- CAT transgene detected with a novel histochemical stain for CAT

  1991cited by this paper
• Transcription initiation in the two leader exons of the rat IGF-I gene occurs from disperse versus localized sites.

  1991cited by this paper
• Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes.

  1991cited by this paper
• Insulin-like growth factor I (IGF-I): a molecular basis for endocrine versus local action?

  1991cited by this paper
• Towards understanding skeletal muscle regeneration.

  1991cited by this paper
• Alternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro.

  1990cited by this paper
• Nucleotide sequence of the bovine insulin-like growth factor 1 (IGF-1) and its IGF-1A precursor.

  1990cited by this paper
• Nucleotide sequence of a genomic fragment of the rat IGF-I gene spanning an alternate 5' non coding exon.

  1989cited by this paper
• The size heterogeneity of rat insulin-like growth factor-I mRNAs is due primarily to differences in the length of 3'-untranslated sequence.

  1989cited by this paper
• The onset of myogenesis in denervated mouse skeletal muscle regenerating after injury.

  1989cited by this paper
• Purification, amino acid sequences and assay cross-reactivities of porcine insulin-like growth factor-I and -II.

  1989cited by this paper
• A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1).

  1989cited by this paper
• Myosin light chain enhancer activates muscle-specific, developmentally regulated gene expression in transgenic mice.

  1989cited by this paper
• Sheep insulin-like growth factors I and II: sequences, activities and assays.

  1989cited by this paper
• Insulin-like growth factor I messenger ribonucleic acids with alternative 5'-untranslated regions are differentially expressed during development of the rat.

  1989cited by this paper
• Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide.

  1989cited by this paper
• Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver.

  1988cited by this paper
• Transcripts of alpha-cardiac and alpha-skeletal actins are early markers for myogenesis in the mouse embryo.

  1988cited by this paper
• Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form.

  1988cited by this paper
• Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene.

  1987cited by this paper
• Differential expression of alternative 5' untranslated regions in mRNAs encoding rat insulin-like growth factor I.

  1987cited by this paper
• Differential patterns of transcript accumulation during human myogenesis

  1987cited by this paper
• Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues.

  1987cited by this paper
• Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors.

  1986influential reference
• Isolation and characterization of variant IGF‐1 as well as IGF‐2 from adult human brain

  1986cited by this paper
• Complete characterization of the human IGF‐I nucleotide sequence isolated from a newly constructed adult liver cDNA library

  1986cited by this paper
• Two insulin-like growth factor I messenger RNAs are expressed in human liver.

  1986cited by this paper
• Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides.

  1986cited by this paper
• The fate of proliferating cells in skeletal muscle after denervation or tenotomy: an autoradiographic study.

  1985cited by this paper
• Sequence of cDNA encoding human insulin-like growth factor I precursor

  1983cited by this paper
• Cell proliferation in denervated muscle: identity and origin of dividing cells.

  1982cited by this paper
• The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

  1978cited by this paper

• Osteosarcopenia: epidemiology, molecular mechanisms, and management

  2025cites this paper
• Leptin’s potential mechanisms in ICU-acquired weakness

  2025cites this paper
• Skeletal muscle

  2022cites this paper
• Growth performance, carcass traits, muscle fiber characteristics and skeletal muscle mRNA abundance in hair lambs supplemented with ferulic acid

  2022cites this paper
• Procollagen type III amino‐terminal propeptide and insulin‐like growth factor I as biomarkers of growth hormone administration

  2021cites this paper
• Microarray profiling of gene expression in C2C12 myotubes trained by electric pulse stimulation.

  2021cites this paper
• Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice

  2021cites this paper
• Association analysis of IGF2 gene polymorphisms with growth traits of Dezhou donkey

  2021cites this paper
• Al-Azhar Un. Journal for Research and Studies. Vol 3(1) Dec.2021

  2021cites this paper
• Controlled Delivery of Insulin-like Growth Factor-1 from Bioactive Glass-Incorporated Alginate-Poloxamer/Silk Fibroin Hydrogels

  2020cites this paper
• Role of Alternatively Spliced Messenger RNA (mRNA) Isoforms of the Insulin-Like Growth Factor 1 (IGF1) in Selected Human Tumors

  2020influential citation
• CRISPR‐Cas9–induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression

  2020cites this paper
• Recombinant human insulin‐like growth factor‐1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy

  2020cites this paper
• Amelioration of Myogenin, Bcl-2 expression and DNA damages in myocytes of Trichinella spiralis-infected mice after immunization with gamma radiation-attenuated larvae

  2020cites this paper
• Effects of IGF‐1 isoforms on muscle growth and sarcopenia

  2019cites this paper
• Disparate Central and Peripheral Effects of Circulating IGF-1 Deficiency on Tissue Mitochondrial Function

  2019cites this paper
• “Immunolocalization and effect of low concentrations of Insulin like growth factor‐1 (IGF‐1) in the canine ovary”

  2019cites this paper
• Changes in Skeletal Muscle and Body Weight on Sleeping Beauty Transposon-Mediated Transgenic Mice Overexpressing Pig mIGF-1

  2018cites this paper
• Critical Windows for the Programming Effects of Early-Life Nutrition on Skeletal Muscle Mass.

  2018cites this paper
• Molecular Insights into Muscle Homeostasis, Atrophy and Wasting

  2018cites this paper
• Selection for growth rate and body size have altered the expression profiles of somatotropic axis genes in chickens

  2018cites this paper
• Androgen interacts with exercise through the mTOR pathway to induce skeletal muscle hypertrophy

  2017cites this paper
• AWARD NUMBER: W81XWH-13-1-0407 TITLE: Novel Therapy for Bone Regeneration in Large Segmental Defects PRINCIPAL INVESTIGATOR: Melissa Kacena CONTRACTING ORGANIZATION: INDIANA UNIVERSITY

  2017cites this paper
• AWARD NUMBER: W81XWH-13-1-0501 TITLE: Novel Therapy for Bone Regeneration in Large Segmental Defects PRINCIPAL INVESTIGATOR: Tien-Min Chu CONTRACTING ORGANIZATION: Indiana University Indianapolis, IN 46202-5211

  2017cites this paper
• Upregulation of Akt signaling enhances femoral fracture healing by accelerating atrophic quadriceps recovery.

  2017cites this paper
• IGF1 stimulates greater muscle hypertrophy in the absence of myostatin in male mice.

  2017cites this paper
• Insulin-like Growth Factor-1 and Its Related Signalling During Aging: Modulation by Dietary Restriction

  2017cites this paper
• Stem Cells and Tissue Niche: Two Faces of the Same Coin of Muscle Regeneration

  2016cites this paper
• Folate deprivation induces cell cycle arrest at G0/G1 phase and apoptosis in hippocampal neuron cells through down-regulation of IGF-1 signaling pathway.

  2016cites this paper
• AWARD NUMBER: W81XWH-13-1-0501 TITLE: Novel Therapy for Bone Regeneration in Large Segmental Defects PRINCIPAL INVESTIGATOR: Tien-Min Chu CONTRACTING ORGANIZATION: NDIANA UNIVERSITY INDIANAPOLIS IN 46202-5130

  2016cites this paper
• The Preferential Expression pattern of insulin-like growth factor -1 and its isoforms in the gastrocnemius muscle suggests preferential roles in the running and Sedentary Adolescents

  2016cites this paper
• Recombinant human growth hormone and insulin-like growth factor-1 do not affect mitochondrial derived highly reactive oxygen species production in peripheral blood mononuclear cells under conditions of substrate saturation in-vitro

  2016cites this paper
• Muscle-bone interactions during fracture healing

  2015cites this paper
• Finite mixture clustering of human tissues with different levels of IGF-1 splice variants mRNA transcripts

  2015cites this paper
• Enobosarm (GTx-024) Modulates Adult Skeletal Muscle Mass Independently of the Androgen Receptor in the Satellite Cell Lineage.

  2015cites this paper
• AWARD NUMBER: W81XWH-13-1-0500 TITLE: Novel Therapy for Bone Regeneration in Large Segmental Defects PRINCIPAL INVESTIGATOR: Jeffrey Anglen CONTRACTING ORGANIZATION: INDIANA UNIVERSITY

  2015cites this paper
• Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction

  2015cites this paper
• Tkankowa ekspresja insulinopodobnego czynnika wzrostu 1 (IGF-1) w nowotworach jelita grubego

  2015cites this paper
• Adaptation of slow myofibers: the effect of sustained BDNF treatment of extraocular muscles in infant nonhuman primates.

  2015cites this paper
• Novel Therapy for Bone Regeneration in Large Segmental Defects

  2015cites this paper
• The role of mechano-growth factor E peptide in the regulation of osteosarcoma.

  2015cites this paper
• Novel Therapy for Bone Regeneration in Large 5 a

  2014cites this paper
• Bovine and murine tissue expression of insulin like growth factor-I.

  2014cites this paper
• The Complexity of the IGF1 Gene Splicing, Posttranslational Modification and Bioactivity

  2014cites this paper
• Molecular biomarker discovery and physiological assessment of skeletal muscle in cancer cachexia

  2014cites this paper
• Production of Transgenic Nonhuman Primates

  2014cites this paper
• Stem cell and gene therapy for cardiac regeneration

  2014cites this paper
• Lifelong exercise and locally produced insulin‐like growth factor‐1 (IGF‐1) have a modest influence on reducing age‐related muscle wasting in mice

  2014cites this paper
• Biological activity of the e domain of the IGF-1Ec as addressed by synthetic peptides

  2014cites this paper
• Age-dependent alteration in muscle regeneration: the critical role of tissue niche

  2013cites this paper
• Intramuscular administration of PEGylated IGF-I improves skeletal muscle regeneration after myotoxic injury.

  2013cites this paper
• Understanding ALS: new therapeutic approaches

  2013cites this paper
• Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer

  2013cites this paper
• The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging

  2013influential citation
• Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway

  2013cites this paper
• The Effects of Exogenous Human Growth Hormone and Insulin-Like Growth Factor-1 Administration on Mitochondrial Function.

  2013cites this paper
• The role of ghrelin in anorexia-cachexia syndromes.

  2013cites this paper
• Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.

  2013cites this paper
• Differential expression of IGF-1 mRNA isoforms in colorectal carcinoma and normal colon tissue.

  2012cites this paper
• Role of the Intestinal Epithelial Insulin-like Growth Factor-1 Receptor in Glucagon-like Peptide-2-mediated Small Intestinal Growth Responses

  2012cites this paper
• Mechano-growth factor E peptide inhibits the differentiation and mineralization of osteoblasts.

  2012cites this paper
• Insulin-like growth factor-1 overexpression in cardiomyocytes diminishes ex vivo heart functional recovery after acute ischemia.

  2012cites this paper
• The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (review).

  2012influential citation
• E-Peptides Control Bioavailability of IGF-1

  2012cites this paper
• IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells.

  2011cites this paper
• Expression and regulation of excitation-contraction coupling proteins in aging skeletal muscle.

  2011cites this paper
• Insulinlike Growth Factor-1Ec (MGF) Expression in Eutopic and Ectopic Endometrium: Characterization of the MGF E-Peptide Actions In Vitro

  2011cites this paper
• Expression of the insulin-like growth factor 1 (IGF-1) and type I IGF receptor mRNAs in human HLE-B3 lens epithelial cells.

  2011cites this paper
• Role of IGF-1 in Age-Related Loss of Skeletal Muscle Mass and Function

  2011cites this paper
• Atrophy/hypertrophy cell signaling in muscles of young athletes trained with vibrational-proprioceptive stimulation

  2011cites this paper
• Low load resistance training with blood flow restriction : adaptations and mechanisms in young and old people

  2011cites this paper
• GH overexpression causes muscle hypertrophy independent from local IGF-I in a zebrafish transgenic model Rafael Y. KuradomiMarcio A. FigueiredoCarlos F. C. Lanes • Carlos E. da RosaDaniela V. AlmeidaRodrigo Maggioni • Maeli D. P. SilvaLuis F. Marins

  2011cites this paper
• Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and hyperglycaemia on a high-fat diet

  2011cites this paper
• Excitation-Contraction Coupling Regulation in Aging Skeletal Muscle

  2011cites this paper
• Loss of IGF-IEa or IGF-IEb impairs myogenic differentiation.

  2011cites this paper
• Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions

  2011cites this paper
• Molecular mechanisms and treatment options for muscle wasting diseases.

  2011cites this paper
• GH overexpression causes muscle hypertrophy independent from local IGF-I in a zebrafish transgenic model

  2011cites this paper
• Point:Counterpoint: IGF is/is not the major physiological regulator of muscle mass. Counterpoint: IGF is not the major physiological regulator of muscle mass.

  2010cites this paper
• Signalling and the control of skeletal muscle size.

  2010cites this paper
• Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration.

  2010cites this paper
• A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo

  2010cites this paper
• Growth factors, muscle function, and doping.

  2010cites this paper
• Regulation of muscle atrophy in aging and disease.

  2010cites this paper
• Combinatorial Gene Therapy Strategies for Treating Muscular Dystrophies

  2010cites this paper
• Genetic Enhancement of Cardiac Regeneration

  2010cites this paper
• Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels.

  2010cites this paper
• Links between the IGF-1 signalling pathways and skeletal muscle hypertrophy in sheep

  2009influential citation
• IGF-I and GH: potential use in gene doping.

  2009cites this paper
• Fibrotic pathways in the dystrophin deficient heart

  2009cites this paper
• Running on empty: how p53 controls INS/IGF signaling and affects life span.

  2009cites this paper
• IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions in Rat Cardiomyocytes in Vitro

  2009cites this paper
• Estrogen-mediated Regulation of Igf1 Transcription and Uterine Growth Involves Direct Binding of Estrogen Receptor α to Estrogen-responsive Elements*

  2009cites this paper
• The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice

  2009cites this paper
• Expression and subcellular localization of mechano-growth factor in osteoblasts under mechanical stretch

  2009cites this paper
• C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1.

  2009cites this paper
• Role of IGF-I in skeletal muscle mass maintenance.

  2009cites this paper
• Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy.

  2009cites this paper
• Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1

  2009cites this paper
• Muscle involvement and IGF-1 signaling in genetic disorders: new therapeutic approaches.

  2009cites this paper